184 related articles for article (PubMed ID: 36347834)
1. HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms.
Han BY; Liu Z; Hu X; Ling H
Cell Death Dis; 2022 Nov; 13(11):940. PubMed ID: 36347834
[TBL] [Abstract][Full Text] [Related]
2. Alternative Splicing Factor Heterogeneous Nuclear Ribonucleoprotein U as a Promising Biomarker for Gastric Cancer Risk and Prognosis with Tumor-Promoting Properties.
Dong YY; Wang MY; Jing JJ; Wu YJ; Li H; Yuan Y; Sun LP
Am J Pathol; 2024 Jan; 194(1):13-29. PubMed ID: 37923250
[TBL] [Abstract][Full Text] [Related]
3. HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/AXIN2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical Cancer.
Niu Z; Wang F; Lv S; Lv Y; Liu M; Fu L; Yao Y; Wang L; Lin W; Yuan F
Mol Cell Biol; 2021 Sep; 41(10):e0011521. PubMed ID: 34309414
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis.
Cui S; Zhang Y; Xing L; Li R; Piao Y; Liu H
Environ Toxicol; 2022 Jun; 37(6):1483-1494. PubMed ID: 35343646
[TBL] [Abstract][Full Text] [Related]
5. CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis.
Han S; Hao H; Han H; Xue D; Jiao Y; Xie Y; Xu Y; Huangfu L; Fu J; Wang S; Sun H; Li P; Zhou Q
Cells; 2022 Sep; 11(19):. PubMed ID: 36231027
[TBL] [Abstract][Full Text] [Related]
6. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
7. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
Che Y; Bai M; Lu K; Fu L
Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
[TBL] [Abstract][Full Text] [Related]
8. Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor.
Germann S; Gratadou L; Zonta E; Dardenne E; Gaudineau B; Fougère M; Samaan S; Dutertre M; Jauliac S; Auboeuf D
Oncogene; 2012 Oct; 31(42):4536-49. PubMed ID: 22266867
[TBL] [Abstract][Full Text] [Related]
9. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
10. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
11. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway.
Li Z; Yang HY; Zhang XL; Zhang X; Huang YZ; Dai XY; Shi L; Zhou GR; Wei JF; Ding Q
J Exp Clin Cancer Res; 2022 May; 41(1):168. PubMed ID: 35524313
[TBL] [Abstract][Full Text] [Related]
12. Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1.
He H; Song D; Sinha I; Hessling B; Li X; Haldosen LA; Zhao C
Oncogene; 2019 Jul; 38(28):5725-5738. PubMed ID: 31015574
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
[TBL] [Abstract][Full Text] [Related]
14. An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression.
Lu XX; Yang WX; Pei YC; Luo H; Li XG; Wang YJ; Zhang GL; Ling H; Shao ZM; Hu X
Cancer Res; 2023 Jun; 83(12):2000-2015. PubMed ID: 37057875
[TBL] [Abstract][Full Text] [Related]
15. SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1.
Deng L; Liao L; Zhang YL; Yang SY; Hu SY; Andriani L; Ling YX; Ma XY; Zhang FL; Shao ZM; Li DQ
Sci Adv; 2024 Apr; 10(14):eadj4009. PubMed ID: 38569025
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous nuclear ribonucleoprotein U-actin complex derived from extracellular vesicles facilitates proliferation and migration of human coronary artery endothelial cells by promoting RNA polymerase II transcription.
Wang H; Liu H; Zhao X; Chen X
Bioengineered; 2022 May; 13(5):11469-11486. PubMed ID: 35535400
[TBL] [Abstract][Full Text] [Related]
18. HNRNPU's multi-tasking is essential for proper cortical development.
Sapir T; Reiner O
Bioessays; 2023 Sep; 45(9):e2300039. PubMed ID: 37439444
[TBL] [Abstract][Full Text] [Related]
19. HNRNPU promotes the progression of hepatocellular carcinoma by enhancing CDK2 transcription.
Liang Y; Fan Y; Liu Y; Fan H
Exp Cell Res; 2021 Dec; 409(1):112898. PubMed ID: 34737140
[TBL] [Abstract][Full Text] [Related]
20. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
